Malignant melanocytes showed atypical, hyperchromatic nuclei and low mitotic count (23 mitotic figures per 10 HPF)
"It's important if somebody does start experiencing some new symptoms of any kind on these medications, we have to remember we don't have very long-term data on these meds, so there are still a lot of unknown risks with these medications," Parrella said
However, when PDA@Pt was at a concentration of 100 g/mL, the cell viability of FLS dropped to 76.2%, indicating that PDA@Pt is essentially non-toxic to HUVEC but has mild toxicity to FLS (Figure S13a-b)
As more patients begin this once-weekly injectable medication, questions arise about potential side effects, including whether tirzepatide causes nightmares
H ypothalamic-autonomic control of energy homeostasis
Published online May 22, 2024:S0002-9343(24)00334-6